1.
Antiangiogenic activity of zoledronic acid: inhibition of the VEGF-VEGFR-2 autocrine loop in the endothelial cells of patients with multiple myeloma. Hematol Meeting Rep. 2009;2(3). doi:10.4081/hmr.v2i3.376